Replies to post #180968 on Biotech Values

[DewDiligence]

Zytiga + Xtandi simultaneous treatment probably isn’t reimbursed by most third-party payers.

[DewDiligence]

MDVN—FDA approves Xtandi for pre-chemo use in CRPC; the expanded label:

http://t.co/CRqCloczcK

H/t @AndyBiotech.

[DewDiligence]

CHMP approves MDVN’s Xtandi for pre-chemo CRPC:

http://finance.yahoo.com/news/xtandi-enzalutamide-capsules-receive-positive-130600800.html

Rubber-stamped approval for EU marketing will follow in 2-3 months.

FDA approved Xtandi in this indication on 9/10/14 (#msg-106140201).